Lilian Pfeiffer Lcsw P.a. - Medicare Mental Health Clinic in Pembroke Pines, FL

Lilian Pfeiffer Lcsw P.a. is a medicare enrolled mental health clinic (Clinic/center - Mental Health (including Community Mental Health Center)) in Pembroke Pines, Florida. The current practice location for Lilian Pfeiffer Lcsw P.a. is 600 N Hiatus Rd, Suite 201, Pembroke Pines, Florida. For appointments, you can reach them via phone at (954) 801-5312. The mailing address for Lilian Pfeiffer Lcsw P.a. is 1950 Nw 107th Ave, Pembroke Pines, Florida and phone number is (954) 801-5312.

Lilian Pfeiffer Lcsw P.a. is licensed to practice in Florida (license number SW 4823). The clinic also participates in the medicare program and its NPI number is 1639423890. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (954) 801-5312.

Contact Information

Lilian Pfeiffer Lcsw P.a.
600 N Hiatus Rd
Suite 201
Pembroke Pines
FL 33026-5207
(954) 801-5312
(954) 212-0477

Mental Health Clinic Profile

Full NameLilian Pfeiffer Lcsw P.a.
SpecialityClinic/Center
Location600 N Hiatus Rd, Pembroke Pines, Florida
Authorized Official Name and PositionLilian Pfeiffer (PRESIDENT)
Authorized Official Contact9548015312
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Lilian Pfeiffer Lcsw P.a.
1950 Nw 107th Ave
Pembroke Pines
FL 33026-2318

Ph: (954) 801-5312
Lilian Pfeiffer Lcsw P.a.
600 N Hiatus Rd
Suite 201
Pembroke Pines
FL 33026-5207

Ph: (954) 801-5312

NPI Details:

NPI Number1639423890
Provider Enumeration Date11/08/2012
Last Update Date11/08/2012

Medicare PECOS Information:

Medicare PECOS PAC ID8022254010
Medicare Enrollment IDO20130417000506

News Archive

Overweight and obese women with breast cancer may be undertreated

Overweight and obese women with breast cancer may receive reduced doses of chemotherapy drugs, which may put them at greater risk of cancer recurrence, according to a study in the June 13 issue of Archives of Internal Medicine.

Zacharon, Pfizer enter research collaboration to develop drugs for orphan diseases

Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.

Scientist granted over $138,000 to explore Vitamin C therapy in sepsis

Sepsis kills more people than breast, colorectal, pancreatic, and prostate cancers combined. Outside of coronary care units, it is the leading cause of mortality in intensive care units. Every year 18 million people worldwide develop this potentially fatal disease. Thanks to a generous grant of $138,238.65 from the Jesse and Julie Rasch Foundation, Lawson Health Research Institute's Dr. Michael Sharpe is exploring a new sepsis therapy using Vitamin C.

Baxter seeks FDA approval of BAX 855 for treatment of people with hemophilia A

Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].

Fasting for blood test can lead to hypoglycemia in patients who take diabetes medications

Fasting before getting your blood drawn for cholesterol tests is common practice, but new research from Michigan State University shows it is a contributing factor of low blood sugar, or hypoglycemia, in patients who take diabetes medications.

Read more Medical News

› Verified 3 days ago

Medical Identifiers

Medical identifiers for Lilian Pfeiffer Lcsw P.a. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1639423890NPI-NPPES
E0496AOtherFLMEDICARE PTAN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
261QM0801XClinic/center - Mental Health (including Community Mental Health Center) SW 4823 (Florida)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Lilian Pfeiffer Lcsw P.a. acts as a billing entity for following providers:
Provider NameLilian Pfeiffer
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1477697399
PECOS PAC ID: 8628028651
Enrollment ID: I20050131000734

News Archive

Overweight and obese women with breast cancer may be undertreated

Overweight and obese women with breast cancer may receive reduced doses of chemotherapy drugs, which may put them at greater risk of cancer recurrence, according to a study in the June 13 issue of Archives of Internal Medicine.

Zacharon, Pfizer enter research collaboration to develop drugs for orphan diseases

Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.

Scientist granted over $138,000 to explore Vitamin C therapy in sepsis

Sepsis kills more people than breast, colorectal, pancreatic, and prostate cancers combined. Outside of coronary care units, it is the leading cause of mortality in intensive care units. Every year 18 million people worldwide develop this potentially fatal disease. Thanks to a generous grant of $138,238.65 from the Jesse and Julie Rasch Foundation, Lawson Health Research Institute's Dr. Michael Sharpe is exploring a new sepsis therapy using Vitamin C.

Baxter seeks FDA approval of BAX 855 for treatment of people with hemophilia A

Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].

Fasting for blood test can lead to hypoglycemia in patients who take diabetes medications

Fasting before getting your blood drawn for cholesterol tests is common practice, but new research from Michigan State University shows it is a contributing factor of low blood sugar, or hypoglycemia, in patients who take diabetes medications.

Read more Medical News

› Verified 3 days ago

News Archive

Overweight and obese women with breast cancer may be undertreated

Overweight and obese women with breast cancer may receive reduced doses of chemotherapy drugs, which may put them at greater risk of cancer recurrence, according to a study in the June 13 issue of Archives of Internal Medicine.

Zacharon, Pfizer enter research collaboration to develop drugs for orphan diseases

Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.

Scientist granted over $138,000 to explore Vitamin C therapy in sepsis

Sepsis kills more people than breast, colorectal, pancreatic, and prostate cancers combined. Outside of coronary care units, it is the leading cause of mortality in intensive care units. Every year 18 million people worldwide develop this potentially fatal disease. Thanks to a generous grant of $138,238.65 from the Jesse and Julie Rasch Foundation, Lawson Health Research Institute's Dr. Michael Sharpe is exploring a new sepsis therapy using Vitamin C.

Baxter seeks FDA approval of BAX 855 for treatment of people with hemophilia A

Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].

Fasting for blood test can lead to hypoglycemia in patients who take diabetes medications

Fasting before getting your blood drawn for cholesterol tests is common practice, but new research from Michigan State University shows it is a contributing factor of low blood sugar, or hypoglycemia, in patients who take diabetes medications.

Read more News

› Verified 3 days ago

Clinic/Center in Pembroke Pines, FL

Efrain Mendez, Md Pa
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1601 N Palm Ave, Suite 110a, Pembroke Pines, FL 33026
Phone: 954-399-8422    Fax: 954-399-8001
Hope S Star Group Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 7879 Pines Blvd Ste 101, Pembroke Pines, FL 33024
Phone: 786-531-8431    
Ilyssa Hershey Psyd Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 15757 Pines Blvd, Pmb 311, Pembroke Pines, FL 33027
Phone: 954-849-2012    Fax: 954-499-5913
Rcs Exclusive Therapy, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 823 Nw 208th Ter, Pembroke Pines, FL 33029
Phone: 954-559-0011    
Community Behavioral Management,inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3 Sw 129th Ave Ste 203, Pembroke Pines, FL 33027
Phone: 954-589-2539    
Serenity Aba Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 12542 Pines Blvd, Pembroke Pines, FL 33027
Phone: 954-391-9478    
Associates In Counseling And Psychiatry
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2225 N University Dr, Pembroke Pines, FL 33024
Phone: 954-962-6200    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.